Cas:360-70-3 Nandrolone decanoate manufacturer & supplier

Chemical Name:Nandrolone decanoate

CAS.NO:360-70-3

Synonyms:17b-Hydroxyestr-4-en-3-one 17-Decanoate;(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl decanoate;(17β)-3-Oxoestr-4-en-17-yl decanoate;17b-[(1-Oxodecyl)oxy]estr-4-en-3-one;19-Nortestosterone 17-decanoate;17b-Hydroxy-19-norandrost-4-en-3-one 17-Decanoate;Decanoic acid, (17β)-3-oxoestr-4-en-17-yl ester;Nandrolone decanoate;(8R,9S,10R,13S,14S,17S)-13-Methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yldecanoat;décanoate de (8R,9S,10R,13S,14S,17S)-13-méthyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yle;19-Nortestoterone decanoate;Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17β)-;Estr-4-en-3-one, 17-β-hydroxy-, decanoate

Molecular Formula:C₂₈H₄₄O₃

Molecular Weight:428.647

HS Code:2937290021

Physical and Chemical Properties:

Melting point:33-37ºC

Boiling point:537.2±50.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.525

PSA:43.37000

Exact Mass:428.329041

LogP:8.14

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 17b-Hydroxyestr-4-en-3-one 17-Decanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Estr-4-en-3-one, 17-β-hydroxy-, decanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(8R,9S,10R,13S,14S,17S)-13-Methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yldecanoat Use and application,(8R,9S,10R,13S,14S,17S)-13-Methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yldecanoat technical grade,usp/ep/jp grade.

Related News: Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company. (4-methoxyphenyl)-(1H-pyrazol-5-yl)methanone manufacturers For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. N-(3-(bicyclo[2.2.1]heptan-2-ylmethyl)-1-methyl-1H-pyrazol-5-yl)-N-(3-cyanobenzyl)-2-phenoxyacetamide suppliers Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company. 4-[5-(4-chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-N,N-dimethyl-aniline vendor & factory For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod.,However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed.